國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Microbial metabolites." ]

切換: 標籤 | MARC模式 | ISBD

Extremophilic cyanobacteria for nove...

Mandal, Sikha.

Extremophilic cyanobacteria for novel drug development

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Extremophilic cyanobacteria for novel drug developmentby Sikha Mandal, Jnanendra Rath.
作者:	Mandal, Sikha.
其他作者:	Rath, Jnanendra.
出版者:	Cham :Springer International Publishing :2015.
面頁冊數:	vii, 92 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	CyanobacteriaTherapeutic use.
電子資源:	http://dx.doi.org/10.1007/978-3-319-12009-6
ISBN:	9783319120096 (electronic bk.)

Extremophilic cyanobacteria for novel drug development
Mandal, Sikha.

Extremophilic cyanobacteria for novel drug development[electronic resource] /by Sikha Mandal, Jnanendra Rath. - Cham :Springer International Publishing :2015. - vii, 92 p. :ill., digital ;24 cm. - SpringerBriefs in pharmaceutical science & drug development,1864-8118. - SpringerBriefs in pharmaceutical science & drug development..

1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.

This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.

ISBN: 9783319120096 (electronic bk.)

Standard No.: 10.1007/978-3-319-12009-6doiSubjects--Topical Terms:

712565
Cyanobacteria
--Therapeutic use.

LC Class. No.: QR46.5 / .M36 2015

Dewey Class. No.: 615.32939

Extremophilic cyanobacteria for novel drug development
LDR:02566nmm a2200325 a 4500 001 460844
003 DE-He213
005 20150724132457.0
006 m d
007 cr nn 008maaau
008 151110s2015 gw s 0 eng d
020 $a 9783319120096 (electronic bk.)
020 $a 9783319120089 (paper)
024 7 $a 10.1007/978-3-319-12009-6 $2 doi
035 $a 978-3-319-12009-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QR46.5 $b .M36 2015
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.32939 $2 23
090 $a QR46.5 $b .M271 2015
100 1 $a Mandal, Sikha. $3 712563
245 1 0 $a Extremophilic cyanobacteria for novel drug development $h [electronic resource] / $c by Sikha Mandal, Jnanendra Rath.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a vii, 92 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in pharmaceutical science & drug development, $x 1864-8118
505 0 $a 1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
520 $a This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
650 0 $a Cyanobacteria $x Therapeutic use. $3 712565
650 0 $a Drug development. $3 190608
650 0 $a Pharmaceutical microbiology. $3 712566
650 0 $a Extreme environments $x Microbiology. $3 194190
650 0 $a Microbial metabolites. $3 702593
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Rath, Jnanendra. $3 712564
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a SpringerBriefs in pharmaceutical science & drug development. $3 557876
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-12009-6
950 $a Medicine (Springer-11650)